Tubastatin A HCl

Tubastatin A HCl is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more).

Tubastatin A HCl化学構造

CAS No. 1310693-92-5

サイズ 価格(税別) 在庫状況
10mM (1mL in DMSO) JPY 29500 国内在庫あり
JPY 22000 国内在庫あり
JPY 44500 国内在庫あり
JPY 448500 国内在庫なし(納期7~10日)

代表番号: 045-509-1970|電子メール:[email protected]
よく尋ねられる質問

文献中Selleckの製品使用例(47)

製品安全説明書

現在のバッチを見る: 純度: 99.30%
99.30

Tubastatin A HCl関連製品

シグナル伝達経路

HDAC阻害剤の選択性比較

Cell Data

Cell Lines Assay Type Concentration Incubation Time 活性情報 PMID
neuron cultures Kinase assay 2.5 μM induces α-tubulin hyperacetylation 20614936
neuron cultures Function assay ~10 μM protects against glutathione depletion-induced oxidative stress 20614936
134/04 Function assay 7.5 µM impairs myotube formation 22174839
C2C12 Function assay 7.5 µM impairs myotube formation 22174839
HaCaT keratinocytes Function assay 10 μM blocks arsenite from inducing Nrf2 protein translation 22367689
JURL-MK1 Function assay 10 μM enhances cell adhesivity to fibronectin 23022583
CML-T1 Function assay 10 μM enhances cell adhesivity to fibronectin 23022583
K562 Function assay 10 μM enhances cell adhesivity to fibronectin 23022583
HL-60 Function assay 10 μM enhances cell adhesivity to fibronectin 23022583
KMCH Growth inhibitory assay ~10 μM decreases proliferation and anchorage-independent growth 23370327
THP-1 Function assay ~10 μM inhibits TNF-α and IL-6 secretion 23541634
RAW 264.7 Function assay ~10 μM attenuates NO production 23541634
HT3 Function assay ~5 μM induces the differential α-tubulin acetylation 23698468
SiHa Function assay ~5 μM induces the differential α-tubulin acetylation 23698468
CaSki Function assay ~5 μM induces the differential α-tubulin acetylation 23698468
SiHa Function assay ~5 μM inhibits Thapsigargin- or EGF-induced SOCE activation 23698468
CaSki Function assay ~5 μM inhibits Thapsigargin- or EGF-induced SOCE activation 23698468
MCF-7 Growth inhibitory assay 30 μM IC50=15 μM 23798680
MCF-7 Function assay 30 μM increases the microtubule acetylation level. 23798680
MCF-7 Function assay 30 μM stabilizes microtubules against cold-induced depolymerization 23798680
MCF-7 Function assay 15 μM stabilizes microtubules against nocodazole-induced disassembly 23798680
MCF-7 Function assay 30 μM alteres the assembly dynamics of interphase microtubules 23798680
MCF-7 Function assay 30 μM increases the binding of HDAC6 with interphase microtubules 23798680
PC12 Function assay ~3 μM up-regulates anti-oxidative gene expression related to transcription factor XBP1s 24909686
PC12 Growth inhibitory assay ~3 μM reverse H2O2-induced growth inhibition 24909686
HEK293T Function assay ~3 μM up-regulated XBP1s protein level 24909686
HEK293T Function assay ~3 μM delays XBP1s protein degradation via acetylation-mediated proteasomal degradation 24909686
Huh7 Function assay ~5 μM suppresses proliferation of hepatitis C virus replicon with EC50 = 0.3 μM 25108326
SKMEL21 Growth inhibitory assay ~500 nM inhibits cell proliferation 25957812
SKMEL103 Growth inhibitory assay ~500 nM inhibits cell proliferation 25957812
SKMEL28 Growth inhibitory assay ~500 nM inhibits cell proliferation 25957812
WM164 Growth inhibitory assay ~500 nM inhibits cell proliferation 25957812
WM1361a Growth inhibitory assay ~500 nM inhibits cell proliferation 25957812
WM1366 Growth inhibitory assay ~500 nM inhibits cell proliferation 25957812
WM793 Growth inhibitory assay ~500 nM inhibits cell proliferation 25957812
WM35 Growth inhibitory assay ~500 nM inhibits cell proliferation 25957812
WM983a Growth inhibitory assay ~500 nM inhibits cell proliferation 25957812
WM793 Function assay ~6 μM induce G1 arrest 25957812
WM164 Function assay ~6 μM induce G1 arrest 25957812
WM983a Function assay ~6 μM induce G1 arrest 25957812
WM164 Function assay ~3 μM augments expression of MHC class I and melanoma associated antigens 25957812
WM983a Function assay ~3 μM augments expression of MHC class I and melanoma associated antigens 25957812
IPC298 Function assay ~3 μM augments expression of MHC class I and melanoma associated antigens 25957812
SKMEL30 Function assay ~3 μM augments expression of MHC class I and melanoma associated antigens 25957812
293T Function assay ~2 μg/ml induces PTEN expression and membrane translocation 26279303
SACC-83 Function assay ~2 μg/ml induces PTEN expression and membrane translocation 26279303
293T Function assay ~2 μg/ml induces PTEN acetylation at K163 26279303
U-87 MG Function assay ~2 μg/ml inhibits the migration and invasion 26279303
U-87 MG Function assay ~10 μM inhibits AKT phosphorylation 26279303
U-87 MG Growth inhibitory assay ~10 μM inhibits cell growth 26279303
TCa83 Function assay induces PTEN expression and membrane translocation 26279303
他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

生物活性

製品説明 Tubastatin A HCl is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay. It is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more).
Targets
HDAC6 [1]
(Cell-free assay)
HDAC8 [1]
(Cell-free assay)
15 nM 854 nM
In Vitro
In vitro Tubastatin A is substantially selective for all 11 HDAC isoforms and maintains over 1000-fold selectivity against all isoforms excluding HDAC8, where it has approximately 57-fold selectivity. In homocysteic acid (HCA) induced neurodegeneration assays, Tubastatin A displays dose-dependent protection against HCA-induced neuronal cell death starting at 5 μM with near complete protection at 10 μM. [1] At 100 ng/mL Tubastatin A increases Foxp3+ T-regulatory cells (Tregs) suppression of T cell proliferation in vitro. [2] Tubastatin A treatment in C2C12 cells would lead to myotube formation impairment when alpha-tubulin is hyperacetylated early in the myogenic process; however, myotube elongation occurs when alpha-tubulin is hyeperacetylated in myotubes. [3] A recent study indicates that Tubastatin A treatment increases cell elasticity as revealed by atomic force microscopy (AFM) tests without exerting drastic changes to the actin microfilament or microtubule networks in mouse ovarian cancer cell lines, MOSE-E and MOSE-L. [4]
Kinase Assay Enzyme Inhibition Assays
Enzyme inhibition assays are performed by the Reaction Biology Corporation, Malvern, PA, using the Reaction Biology HDAC Spectrum platform. (www.reactionbiology.com) The HDAC1, 2, 4, 5, 6, 7, 8, 9, 10, and 11 assays use isolated recombinant human protein; HDAC3/NcoR2 complex is used for the HDAC3 assay. Substrate for HDAC1, 2, 3, 6, 10, and 11 assays is a fluorogenic peptide from p53 residues 379-382 (RHKKAc); substrate for HDAC8 is fluorogenic diacyl peptide based on residues 379-382 of p53 (RHKAcKAc). Acetyl-Lys (trifluoroacetyl)-AMC substrate is used for HDAC4, 5, 7, and 9 assays. Tubastatin A is dissolved in DMSO and tested in 10-dose IC50 mode with 3-fold serial dilution starting at 30 μM. Control Compound Trichostatin A (TSA) is tested in a 10-dose IC50 with 3-fold serial dilution starting at 5 μM. IC50 values are extracted by curve-fitting the dose/response slopes.
細胞実験 細胞株 Primary cortical neuron of fetal Sprague-Dawley rats (embryonic day 17)
濃度 0-10 μM
反応時間 24 hours
実験の流れ Primary cortical neuron cultures are obtained from the cerebral cortex of fetal Sprague-Dawley rats (embryonic day 17) as described previously. All experiments are initiated 24 hours after plating. Under these conditions, the cells are not susceptible to glutamate-mediated excitotoxicity. For cytotoxicity studies, cells are rinsed with warm PBS and then placed in minimum essential medium (Invitrogen) containing 5.5 g/L glucose, 10% fetal calf serum, 2 mM L-glutamine, and 100 μM cystine. Oxidative stress is induced by the addition of the glutamate analogue homocysteate (HCA; 5 mM) to the media. HCA is diluted from 100-fold concentrated solutions that are adjusted to pH 7.5. In combination with HCA, neurons are treated with Tubastatin A at the indicated concentrations. Viability is assessed after 24 hours by MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method.
実験結果図 Methods Biomarkers 結果図 PMID
Western blot EGFR / p-AKT / AKT / p-ERK / ERK 29665050
Immunofluorescence α-tubulin / Acetylated tubulin HDAC6 23798680
In Vivo
In Vivo Daily treatment of Tubastatin A at 0.5mg/kg inhibits HDAC6 to promote Tregs suppressive activity in mouse models of inflammation and autoimmunity, including multiple forms of experimental colitis and fully major histocompatibility complex (MHC)-incompatible cardiac allograft rejection. [2]
動物実験 動物モデル Na?ve CD45RBhi CD4+ CD25- cells (1 × 106) from WT or HDAC6-/- mice Are injected i.p. into B6/Rag1-/-mice.
投与量 0.5 mg/kg
投与経路 Tubastatin A is injected i.p. daily.

化学情報

分子量 371.86 化学式

C20H21N3O2.HCl

CAS No. 1310693-92-5 SDF Download Tubastatin A HCl SDFをダウンロードする
Smiles CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO.Cl
保管

In vitro
Batch:

DMSO : 100 mg/mL ( (268.91 mM); 吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。)

Water : Insoluble

Ethanol : Insoluble

モル濃度計算器

in vivo
Batch:

Add solvents to the product individually and in order.

投与溶液組成計算機

実験計算

モル濃度計算器

質量 濃度 体積 分子量

投与溶液組成計算機(クリア溶液)

ステップ1:実験データを入力してください。(実験操作によるロスを考慮し、動物数を1匹分多くして計算・調製することを推奨します)

mg/kg g μL

ステップ2:投与溶媒の組成を入力してください。(ロット毎に適した溶解組成が異なる場合があります。詳細については弊社までお問い合わせください)

% DMSO % % Tween 80 % ddH2O
%DMSO %

計算結果:

投与溶媒濃度: mg/ml;

DMSOストック溶液調製方法: mg 試薬を μL DMSOに溶解する(濃度 mg/mL, 注:濃度が当該ロットのDMSO溶解度を超える場合はご連絡ください。 )

投与溶媒調製方法:Take μL DMSOストック溶液に μL PEG300,を加え、完全溶解後μL Tween 80,を加えて完全溶解させた後 μL ddH2O,を加え完全に溶解させます。

投与溶媒調製方法:μL DMSOストック溶液に μL Corn oil,を加え、完全溶解。

注意:1.ストック溶液に沈殿、混濁などがないことをご確認ください;
2.順番通りに溶剤を加えてください。次のステップに進む前に溶液に沈殿、混濁などがないことを確認してから加えてください。ボルテックス、ソニケーション、水浴加熱など物理的な方法で溶解を早めることは可能です。

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

大学・企業名を記入してください
名前を記入してください
電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
お問い合わせ内容をご入力ください
Tags: Tubastatin A HClを買う | Tubastatin A HCl ic50 | Tubastatin A HCl供給者 | Tubastatin A HClを購入する | Tubastatin A HCl費用 | Tubastatin A HCl生産者 | オーダーTubastatin A HCl | Tubastatin A HCl化学構造 | Tubastatin A HCl分子量 | Tubastatin A HCl代理店